Adarza News

/Adarza News
3 02, 2017

St. Louis Post-Dispatch: As Adarza scales up, St. Louis hopes for an important win

By |February 3rd, 2017|Adarza News|0 Comments

As Adarza scales up, St. Louis hopes for an important win.  By David Nicklaus

24 01, 2017

St. Louis Business Journal: RiverVest leads $17M investment in Adarza, brings on new president

By |January 24th, 2017|Adarza News, Adarza Timeline, Blog|0 Comments

RiverVest leads $17 million investment in Adarza, brings on new president

19 01, 2017

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

By |January 19th, 2017|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development [...]

16 01, 2017

Event Update

By |January 16th, 2017|Adarza News|0 Comments

  Join us at the 15th Cytokines & Inflammation Conference, February 6-7, 2017 in San Diego, CA. Booth #6. And check our poster while you’re there: “A Multiplex Panel for Simultaneously Profiling Toxicant Levels and Biological Response Indicators in Serum Samples”.

24 03, 2016

Adarza BioSystems Completes $5 M Series-B Closing

By |March 24th, 2016|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable [...]

25 11, 2014

Horizon Discovery Group plc and Adarza BioSystems Enter Supply & Licensing Agreement

By |November 25th, 2014|Adarza News, Adarza Timeline, Press Releases|0 Comments

Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.

24 10, 2014

Adarza BioSystems Selects Sunedison Semiconductor Site for Manufacturing Immunoassay Consumables

By |October 24th, 2014|Adarza News, Adarza Timeline|0 Comments

Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.

1 10, 2014

Adarza BioSystems Completes $6.8M Series-A Financing

By |October 1st, 2014|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY:  Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate [...]

27 06, 2012

Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program

By |June 27th, 2012|Adarza News, Adarza Timeline|0 Comments

NEWS RELEASE FROM: Missouri Department of Economic Development Date: Thursday, June 27, 2012 JEFFERSON CITY, MO:  The Missouri Technology Corporation (MTC) today announced a significant investment in a life science startup company through its IDEA Funds program. MTC made a $200,000 investment in Adaraza BioSystems, Inc, a life science technology company that has developed a disruptive [...]

20 01, 2011

Adarza is Changing the Future of Diagnostic Testing

By |January 20th, 2011|Adarza News, Adarza Timeline|0 Comments

Having peered into the high-tech future with confidence, Miller and the Adarza team — CEO Rand Henke and chief operating officer Terry Gronwall — now must deal with the timeless issues of the marketplace.